These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 10449665)

  • 1. Hürthle cell carcinoma: A malignancy of low-grade potential.
    Khafif A; Khafif RA; Attie JN
    Head Neck; 1999 Sep; 21(6):506-11. PubMed ID: 10449665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathologic Features of Fatal Non-Anaplastic Follicular Cell-Derived Thyroid Carcinomas.
    Xu B; Ibrahimpasic T; Wang L; Sabra MM; Migliacci JC; Tuttle RM; Ganly I; Ghossein R
    Thyroid; 2016 Nov; 26(11):1588-1597. PubMed ID: 27480016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of thyroid cancer of follicular cell origin: Gundersen/Lutheran Medical Center, 1969-1995.
    Martins RG; Caplan RH; Lambert PJ; Rooney B; Kisken WA
    J Am Coll Surg; 1997 Oct; 185(4):388-97. PubMed ID: 9328388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.
    Tsang RW; Brierley JD; Simpson WJ; Panzarella T; Gospodarowicz MK; Sutcliffe SB
    Cancer; 1998 Jan; 82(2):375-88. PubMed ID: 9445196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does Hürthle cell carcinoma of the thyroid have a poorer prognosis than ordinary follicular thyroid carcinoma?
    Sugino K; Kameyama K; Ito K; Nagahama M; Kitagawa W; Shibuya H; Ohkuwa K; Uruno T; Akaishi J; Suzuki A; Masaki C; Ito K
    Ann Surg Oncol; 2013 Sep; 20(9):2944-50. PubMed ID: 23616135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration?
    Pu RT; Yang J; Wasserman PG; Bhuiya T; Griffith KA; Michael CW
    Diagn Cytopathol; 2006 May; 34(5):330-4. PubMed ID: 16604553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Follicular and Hurthle cell carcinomas of the thyroid: a comparative study.
    Evans HL; Vassilopoulou-Sellin R
    Am J Surg Pathol; 1998 Dec; 22(12):1512-20. PubMed ID: 9850177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiated carcinoma of the thyroid with extrathyroidal extension.
    Andersen PE; Kinsella J; Loree TR; Shaha AR; Shah JP
    Am J Surg; 1995 Nov; 170(5):467-70. PubMed ID: 7485734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiated thyroid carcinoma with distant metastases at presentation: prognostic factors and outcome.
    Haq M; Harmer C
    Clin Endocrinol (Oxf); 2005 Jul; 63(1):87-93. PubMed ID: 15963067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Death from thyroid cancer of follicular cell origin.
    Wu HS; Young MT; Ituarte PH; D'Avanzo A; Duh QY; Greenspan FS; Loh KC; Clark OH
    J Am Coll Surg; 2000 Dec; 191(6):600-6. PubMed ID: 11129807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poorly differentiated oncocytic (hürthle cell) follicular carcinoma: an institutional experience.
    Bai S; Baloch ZW; Samulski TD; Montone KT; LiVolsi VA
    Endocr Pathol; 2015 May; 26(2):164-9. PubMed ID: 25898815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroid cancers. I. Papillary, follicular, and Hürthle cell.
    Goldman ND; Coniglio JU; Falk SA
    Otolaryngol Clin North Am; 1996 Aug; 29(4):593-609. PubMed ID: 8844732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Follicular and Hürthle cell carcinoma: predicting outcome and directing therapy.
    Sanders LE; Silverman M
    Surgery; 1998 Dec; 124(6):967-74. PubMed ID: 9854570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of follicular and Hürthle cell neoplasms of the thyroid gland.
    McHenry CR; Sandoval BA
    Surg Oncol Clin N Am; 1998 Oct; 7(4):893-910. PubMed ID: 9735140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapy concept in differentiated thyroid gland carcinoma--results of 25 years with 257 patients].
    Gemsenjäger E; Heitz PU; Martina B; Schweizer I
    Praxis (Bern 1994); 2000 Nov; 89(44):1779-97. PubMed ID: 11109916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis, treatment, and outcome of follicular thyroid carcinoma.
    Emerick GT; Duh QY; Siperstein AE; Burrow GN; Clark OH
    Cancer; 1993 Dec; 72(11):3287-95. PubMed ID: 8080485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical impact of follicular oncocytic (Hürthle cell) carcinoma in comparison with corresponding classical follicular thyroid carcinoma.
    Wenter V; Albert NL; Unterrainer M; Ahmaddy F; Ilhan H; Jellinek A; Knösel T; Bartenstein P; Spitzweg C; Lehner S; Todica A
    Eur J Nucl Med Mol Imaging; 2021 Feb; 48(2):449-460. PubMed ID: 32683470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of malignancy rate in thyroid nodules with cytology of indeterminate follicular or indeterminate Hürthle cell neoplasm.
    Sorrenti S; Trimboli P; Catania A; Ulisse S; De Antoni E; D'Armiento M
    Thyroid; 2009 Apr; 19(4):355-60. PubMed ID: 19355826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
    Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective treatment of differentiated thyroid carcinoma.
    Gemsenjäger E; Heitz PU; Martina B
    World J Surg; 1997 Jun; 21(5):546-51; discussion 551-2. PubMed ID: 9204746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.